Showing results (1-10 of 196) with videos related to
Sort By:
Pageof 20
Drug Discovery Today|February 15, 2005
Using imaging biomarkers to accelerate drug development and clinical trialsHomer H Pien, Alan J Fischman, James H Thrall, et al.Radiologic Clinics of North America|February 8, 2005
Role of [18F]-dopa-PET imaging in assessing movement disordersAlan J FischmanJournal of the American College of Radiology : JACR|October 4, 2011
Unintended consequences of health care legislationJames H ThrallJournal of the American College of Radiology : JACR|August 26, 2015
Moreton Lecture: Imaging in the Age of Precision MedicineJames H ThrallAcademic Radiology|August 10, 2014
Appropriateness and imaging utilization: "computerized provider order entry and decision support"James H ThrallClinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Evaluation of Rare Tumors with [F-18]Fluorodeoxyglucose Positron Emission TomographyHossein Jadvar, Alan J. FischmanRadiologic Clinics of North America|March 11, 2008
Nuclear imaging in the genitourinary tract: recent advances and future directionsWei He, Alan J FischmanAJR. American Journal of Roentgenology|April 28, 2005
The business of PET/CTSue Halliday, James H ThrallChest|September 15, 2004
Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?Suzanne L Aquino, Alan J FischmanJournal of the American College of Radiology : JACR|April 7, 2007
Clinical molecular imagingJanet C Miller, James H Thrall, Pageof 20